The DOI matches its Crossref record.
Management and Prognostic Features of Intracerebral Hemorrhage During Anticoagulant Therapy: A Swedish Multicenter Study
Open accessAbstract
BACKGROUND AND PURPOSE: Patients treated with oral anticoagulants (ACs) have an increased risk of intracerebral hemorrhage (ICH), which is more often fatal than spontaneous ICH. Options to reverse the AC effect include intravenous administration of vitamin K, plasma, and coagulation factor concentrate. However, the optimal management of AC-related ICH has not been determined in any randomized trial. In this study, the present management of AC-related ICH was surveyed, and determinants of survival were assessed. METHODS: We retrospectively reviewed the medical records of all AC-related ICHs at 10 Swedish hospitals during a 4-year period, 1993 to 1996. Survival status after the ICH was determined from the Swedish National population register. RESULTS: We identified 151 patients with AC-related ICH. Death rates were 53.6% at 30 days, 63.6% at 6 months, and 77.5% at follow-up (mean 3.5 years). The case fatality ratio at 30 days was 96% among patients unconscious on admission (n=27), 80% among patients who became unconscious before active treatment was started (n=15), 55% among patients in whom no special action was taken except withdrawal of AC treatment (n=42), and 28% among patients given active anti-coumarin treatment while they were still conscious (n=64). The case fatality ratio at 30 days was 11% in the group treated with plasma (n=18), 30% in the group treated with vitamin K (n=23), and 39% in the group treated with coagulation factor concentrate (n=23). Within the first 24 to 48 hours after admission, 47% of the patients deteriorated. Choice of therapy to reverse the AC effect differed substantially between the hospitals (P<0.0001), as did the time interval from symptom onset to start of treatment. Multiple logistic regression analysis showed only 2 factors (intraventricular extension of bleeding and ICH volume) that were independently related to case fatality at both 30 days and 6 months. The results were similar when the analysis was restricted to patients who were conscious on admission. CONCLUSIONS: In AC-related ICH, a progressive neurological deterioration during the first 24 to 48 hours after admission is frequent, and the mortality is high. Choice of therapy to reverse the AC effect differed considerably between the hospitals. There was no evidence that any treatment strategy was superior to the others. A randomized controlled trial is needed to determine the best choice of treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Hemphill, J. C., Greenberg, S. M., Anderson, C. S., Becker, K., Bendok, B. R., Cushman, M., Fung, G. L., Goldstein, J. N., Macdonald, R. L., Mitchell, P. H., et al. (2015) · Stroke · doi:10.1161/str.0000000000000069 · Cited by 3,994
Qureshi, A. I., Mendelow, A. D., & Hanley, D. F. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60371-8 · Cited by 1,526
Morgenstern, L. B., Hemphill, J. C., Anderson, C., Becker, K., Broderick, J. P., Connolly, E. S., Greenberg, S. M., Huang, J. N., Macdonald, R. L., Messé, S. R., et al. (2010) · Stroke · doi:10.1161/str.0b013e3181ec611b · Cited by 1,496
Broderick, J., Connolly, S., Feldmann, E., Hanley, D., Kase, C., Krieger, D., Mayberg, M., Morgenstern, L., Ogilvy, C. S., Vespa, P., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.183689 · Cited by 1,125
Eikelboom, J. W., Wallentin, L., Connolly, S. J., Ezekowitz, M., Healey, J. S., Oldgren, J., Yang, S., Alings, M., Kaatz, S., Hohnloser, S. H., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.004747 · Cited by 1,081
Frontera, J. A., Lewin III, J. J., Rabinstein, A. A., Aisiku, I. P., Alexandrov, A. W., Cook, A. M., del Zoppo, G. J., Kumar, M. A., Peerschke, E. I. B., Stiefel, M. F., et al. (2016) · Neurocritical Care · doi:10.1007/s12028-015-0222-x · Cited by 706
Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis
Poon, M. T. C., Fonville, A. F., & Al-Shahi Salman, R. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306476 · Cited by 653
Friberg, L., Rosenqvist, M., & Lip, G. Y. H. (2012) · Circulation · doi:10.1161/circulationaha.111.055079 · Cited by 454
(2006) · Cerebrovascular Diseases · doi:10.1159/000094831 · Cited by 411
Broderick, J., Connolly, S., Feldmann, E., Hanley, D., Kase, C., Krieger, D., Mayberg, M., Morgenstern, L., Ogilvy, C. S., Vespa, P., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.183689 · Cited by 357
Huttner, H. B., Schellinger, P. D., Hartmann, M., Köhrmann, M., Juettler, E., Wikner, J., Mueller, S., Meyding-Lamade, U., Strobl, R., Mansmann, U., et al. (2006) · Stroke · doi:10.1161/01.str.0000221786.81354.d6 · Cited by 335
Zhou, W., Schwarting, S., Illanes, S., Liesz, A., Middelhoff, M., Zorn, M., Bendszus, M., Heiland, S., van Ryn, J., & Veltkamp, R. (2011) · Stroke · doi:10.1161/strokeaha.111.624650 · Cited by 324
Evidence‐based practice guidelines for plasma transfusion
Roback, J. D., Caldwell, S., Carson, J., Davenport, R., Drew, M. J., Eder, A., Fung, M., Hamilton, M., Hess, J. R., Luban, N., et al. (2010) · Transfusion · doi:10.1111/j.1537-2995.2010.02632.x · Cited by 316
PABINGER, I., BRENNER, B., KALINA, U., KNAUB, S., NAGY, A., & OSTERMANN, H. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02904.x · Cited by 315
Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage
Goldstein, J. N., Fazen, L. E., Snider, R., Schwab, K., Greenberg, S. M., Smith, E. E., Lev, M. H., & Rosand, J. (2007) · Neurology · doi:10.1212/01.wnl.0000257087.22852.21 · Cited by 307
Treatment of Warfarin-Associated Intracerebral Hemorrhage: Literature Review and Expert Opinion
Aguilar, M. I., Hart, R. G., Kase, C. S., Freeman, W. D., Hoeben, B. J., García, R. C., Ansell, J. E., Mayer, S. A., Norrving, B., Rosand, J., et al. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)60970-1 · Cited by 306
Self-citationSteiner, T., Rosand, J., & Diringer, M. (2006) · Stroke · doi:10.1161/01.str.0000196989.09900.f8 · Cited by 298
Steiner, T., Diringer, M. N., Schneider, D., Mayer, S. A., Begtrup, K., Broderick, J., Skolnick, B. E., & Davis, S. M. (2006) · Neurosurgery · doi:10.1227/01.neu.0000232837.34992.32 · Cited by 275
CONTRAST EXTRAVASATION ON CT ANGIOGRAPHY PREDICTS HEMATOMA EXPANSION IN INTRACEREBRAL HEMORRHAGE
Murai, Y., Ikeda, Y., & Teramoto, A. (2007) · Neurology · doi:10.1212/01.wnl.0000278894.44311.0b · Cited by 261
Hanley, J. P. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.008904 · Cited by 215
Reversal strategies for vitamin Kantagonists in acute intracerebral hemorrhage
Parry‐Jones, A. R., Di Napoli, M., Goldstein, J. N., Schreuder, F. H. B. M., Tetri, S., Tatlisumak, T., Yan, B., van Nieuwenhuizen, K. M., Dequatre‐Ponchelle, N., Lee‐Archer, M., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24416 · Cited by 90
Metadata
- Authors
- Sjoblom, L., Hardemark, H.-G., Lindgren, A., Norrving, B., Fahlen, M., Samuelsson, M., Stigendal, L., Stockelberg, D., Taghavi, A., Wallrup, L., & Wallvik, J.
- Venue
- Stroke
- Published
- 2001-11-01
- Volume
- 32
- Issue
- 11
- Pages
- 2567-2574
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2015117150
- Cited by
- 229
- References
- 0
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.